INSP · Inspire Medical Systems, Inc. · Webcasts, Transcripts & Audio
$61.10
+0.56 (+0.93%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.77B
Shares
28.97M
Volume · Nov 13
574.42K
Avg daily vol (3M)
759.49K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Inspire Medical Systems, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Inspire Medical Systems, Inc. (INSP), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-10
Inspire Medical Systems, Inc. (INSP) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-02
Inspire Medical Systems, Inc. (INSP) Q3 2026 Earnings Call Transcript
Positive tone
Coding and reimbursement
2027 growth outlook
Clinical evidence and market expansion
Revenue
$206.69M
▼ 7.9% YoY Diluted EPS
$-0.84
▼ 347.1% YoY Gross margin
86.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-09
Inspire Medical Systems, Inc. (INSP) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-03
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
Revenue
$200.58M
▼ 7.6% YoY Diluted EPS
$0.01
Gross margin
85.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-04
Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript
Cautious tone
Coding and reimbursement challenges for Inspire V
WISER government prior authorization program
Long-term CPT code path effective 2028
Revenue
$204.58M
▲ 1.6% YoY Diluted EPS
$-0.39
▼ 490% YoY Gross margin
86.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-04-30
Inspire Medical Systems, Inc. (INSP) April 30, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-11
Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript
Cautious tone
Inspire 5 coding and reimbursement
Inspire 5 launch and clinical performance
WISER prior authorization program
Revenue
$269.08M*
▲ 12.2% YoY Gross margin
86.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Inspire Medical Systems, Inc. (INSP) Q3 2025 Earnings Call Transcript
Confident tone
Inspire V Launch and Adoption
Revenue and Earnings Guidance
GLP-1 Drugs and Patient Funnel
Revenue
$224.50M
▲ 10.5% YoY Diluted EPS
$0.34
▼ 43.3% YoY Gross margin
85.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Inspire Medical Systems, Inc. (INSP) Q2 2025 Earnings Call Transcript
Cautious tone
Inspire V Commercial Rollout Challenges
Revised Full Year 2025 Guidance
CPT Code 64568 / Medicare Reimbursement
Revenue
$217.09M
▲ 10.8% YoY Diluted EPS
$-0.12
▼ 137.5% YoY Gross margin
84.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript
Confident tone
Inspire V full launch
International expansion
Medical education and provider capacity
Revenue
$201.32M
▲ 22.7% YoY Diluted EPS
$0.10
Gross margin
84.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-10
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Confident tone
Inspire V product launch and ramp
Financial performance and 2025 guidance
Medical education and provider training
Revenue
$239.72M*
▲ 24.5% YoY Gross margin
85.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript
Confident tone
Inspire V product launch
Revenue growth and guidance raise
SleepSync and digital initiatives
Revenue
$203.19M
▲ 32.5% YoY Diluted EPS
$0.60
Gross margin
84.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Inspire Medical Systems, Inc. (INSP) Q2 2024 Earnings Call Transcript
Confident tone
Revenue growth and guidance raise
EU MDR certification and France reimbursement
U.S. commercial expansion
Revenue
$195.88M
▲ 29.6% YoY Diluted EPS
$0.32
Gross margin
84.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript
Confident tone
GLP-1 complementary positioning
Direct-to-consumer and medical education
Product innovation and pipeline
Revenue
$164.01M
▲ 28.2% YoY Diluted EPS
$-0.34
Gross margin
84.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-06
Inspire Medical Systems, Inc. (INSP) Q4 2023 Earnings Call Transcript
Confident tone
Revenue growth and 2024 guidance
GLP-1 and patient pipeline
Operating income and profitability
Revenue
$192.51M*
▲ 39.6% YoY Gross margin
85.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Inspire Medical Systems, Inc. (INSP) Q3 2023 Earnings Call Transcript
Revenue
$153.30M
▲ 40.4% YoY Diluted EPS
$-0.29
Gross margin
84.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript
Revenue
$151.09M
▲ 65.3% YoY Diluted EPS
$-0.41
Gross margin
83.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Inspire Medical Systems, Inc. (INSP) Q1 2023 Earnings Call Transcript
Revenue
$127.90M
▲ 84.3% YoY Diluted EPS
$-0.53
Gross margin
84.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-07
Inspire Medical Systems, Inc. (INSP) Q4 2022 Earnings Call Transcript
Revenue
$137.90M*
▲ 75.9% YoY Gross margin
83.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Inspire Medical Systems, Inc. (INSP) Q3 2022 Earnings Call Transcript
Revenue
$109.19M
▲ 77% YoY Diluted EPS
$-0.60
Gross margin
81.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Inspire Medical Systems, Inc. (INSP) Q2 2022 Earnings Call Transcript
Revenue
$91.39M
▲ 72.6% YoY Diluted EPS
$-0.53
Gross margin
84.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Inspire Medical Systems, Inc. (INSP) Q1 2022 Earnings Call Transcript
Revenue
$69.38M
▲ 71.9% YoY Diluted EPS
$-0.61
Gross margin
85.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-18
Inspire Medical Systems, Inc. (INSP) Q4 2021 Earnings Call Transcript
Revenue
$78.40M*
▲ 70.4% YoY Gross margin
85.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Inspire Medical Systems, Inc. (INSP) Q3 2021 Earnings Call Transcript
Revenue
$61.69M
▲ 72.1% YoY Diluted EPS
$-0.38
Gross margin
86.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Inspire Medical Systems, Inc. (INSP) Q2 2021 Earnings Call Transcript
Revenue
$52.96M
▲ 334.7% YoY Diluted EPS
$-0.48
Gross margin
85.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Inspire Medical Systems, Inc. (INSP) Q1 2021 Earnings Call Transcript
Revenue
$40.35M
▲ 89% YoY Diluted EPS
$-0.60
Gross margin
85.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Inspire Medical Systems, Inc. (INSP) Q4 2020 Earnings Call Transcript
Revenue
$46.01M
▲ 71% YoY Gross margin
84.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Inspire Medical Systems, Inc. (INSP) Q3 2020 Earnings Call Transcript
Revenue
$35.84M
▲ 71.8% YoY Diluted EPS
$-0.39
Gross margin
85.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Inspire Medical Systems, Inc. (INSP) Q2 2020 Earnings Call Transcript
Revenue
$12.18M
▼ 32.4% YoY Diluted EPS
$-0.88
Gross margin
84.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Inspire Medical Systems, Inc. (INSP) Q1 2020 Earnings Call Transcript
Revenue
$21.35M
▲ 31.4% YoY Gross margin
84.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Inspire Medical Systems, Inc. (INSP) Q4 2019 Earnings Call
Revenue
$26.91M
▲ 62.5% YoY Gross margin
84.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–31 of 31 webcasts
Key facts
CIK
1609550
CUSIP
457730109
13F (30d)
226 filings
207 filers
Visit website
Investor relations